ClinVar Miner

Submissions for variant NM_005249.5(FOXG1):c.503G>C (p.Gly168Ala)

gnomAD frequency: 0.00048  dbSNP: rs148157138
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel RCV001507039 SCV001711988 benign FOXG1 disorder 2021-03-26 reviewed by expert panel curation The allele frequency of the p.Gly168Ala variant in FOXG1 is 0.18% in African sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). Computational analysis prediction tools suggest that the p.Gly168Ala variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Gly168Ala variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BP4).
GeneDx RCV001704986 SCV000241036 benign not provided 2019-10-25 criteria provided, single submitter clinical testing
Invitae RCV000540363 SCV000650052 likely benign Rett syndrome, congenital variant 2024-01-22 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000187444 SCV000709200 likely benign not specified 2017-06-23 criteria provided, single submitter clinical testing
Ambry Genetics RCV002317097 SCV000850407 benign Inborn genetic diseases 2019-04-25 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
CeGaT Center for Human Genetics Tuebingen RCV001704986 SCV004129156 likely benign not provided 2022-11-01 criteria provided, single submitter clinical testing FOXG1: PP2, BS1
PreventionGenetics, part of Exact Sciences RCV003947570 SCV004760075 likely benign FOXG1-related condition 2021-06-01 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.